Email this article Vitrum osteomag in prevention of osteoporosis inpostmenopausal women: results of the comparative openmulticenter trial
- Authors: Benevolenskaya LI1, Toroptsova NV1, Nikitinskaya OA1, Sharapova EP1, Kororkova TA1, Rozhinskaya LY.1, Marova EI1, Dzeranova LK1, Molitvoslovova NN1, Menshikova LV1, Grudinina OV1, Lesnyak ОM1, Evstigneeva LP1, Smetnik VP1, Shestakova IG1, Kuznetsov SY.1
-
Affiliations:
- Issue: Vol 79, No 11 (2004)
- Pages: 88-93
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29970
- ID: 29970
Cite item
Full Text
Abstract
600 mg calcium (1500 mg calcium carbonate), 200IU of cholecalcepherol, 40 mg of magnesium,
zinc (7.5 mg), copper (1 mg), manganese (1.8 mg) and boron (250 meg) in women with osteopenia for
prevention of osteoporosis
Material and methods. Л multicenter comparative open trial ofvitrum osteomag influence on mineral
bone density (MED), change of pain syndrome in bones, index of calcium-phosphorous metabolism
covered 334 postmenopausal women with osteopenia. MBD was measured in low-back spine and proximal
part of the hip with DEXA method. All the patients were divided into 3 groups: 125 women taking
2 tablets ofvitrum osteomag daily for 12 months (group 1); 111 women taking 1500 mg calcium carbonate
(group 2); 96 women - control group (only observation).
Results. Vitrum osteomag relieved pain in the back and joints, had a positive effect on bone density
(+1.5%) and proximal parts of the hip (0.6-0.93%) exceeding the effect of calcium carbonate only
which preserves the initial MBD in low back spine but does not prevent bone loss in the hip. MBD dynamics
in patients given vitrum osteomag differs essentially from one in the control group (from -1.9
to -2.91%) which demonstrates a reliable preventive anti-osteoporotic effect of this medication. The
drug increases the level of general and ionized calcium in blood but does not cause hypercalcemia
lowering the level of parathormone in blood. The rate of side effects in group 1 was 14,4% and did not
differ much from that in group 2 (16.2%).
Conclusion. The results of the study allow to recommend vitrum osteomag for prophylaxis of a rapid
loss of bone tissue mineral density.
About the authors
L I Benevolenskaya
N V Toroptsova
O A Nikitinskaya
E P Sharapova
T A Kororkova
L Ya Rozhinskaya
E I Marova
L K Dzeranova
N N Molitvoslovova
L V Menshikova
O V Grudinina
О M Lesnyak
L P Evstigneeva
V P Smetnik
I G Shestakova
S Yu Kuznetsov
References
- Беневоленская Л. И. Общие принципы профилактики и лечения остеопороза. Консилиум 2002; 2 (6): 240-244.
- Drown J. P., Josse R. G. Clinical practice guidelines for the diagnosis management of osteoporosis in Canada. Can. Med. Assoc. J. 2002; 12 (suppl. 10): 167.
- Дедух Н. В., Бенгус Л. М., Басти А. Магний и костная ткань (обзор литературы и собственные данные). Остеопороз и остеопатии 2003; 1: 18-22.
- Rude R. R. Magnezium deficiency; a possible risk factor for osteoporosis. In: Burckhard P., Dowson-Hughes В., Heaney R. P., eds. Nutritional aspects of osteoporosis. San Diego: Academic Press 2001. 263-271.
- Shea В., Wells G., et al. Calcium supplementation on bone loss in postmenopausal women. (Cochrane review). Cochrane Library 2004; 1.
- Conlan D. Korula R. Serum copper levels in elderly patients with femoral neek fractures. Age and Ageing 1990; 19: 212- 214.
- Орбелис Д. Новый подход к проблеме микроэлементов. Микроэлементы в мед. 2002; 3(1): 2-7.
- Aloia J. F., Vaswani A., Yen J. К. et al. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann. Intern. Med. 1994; 120: 97- 103.
- Торопцова Н. В., Беневоленская Л. И. Профилактика осгеопороза и переломов. В кн.: Руководство по остеопорозу. М.: Бином; 2003; гл. 16: 320-344.
Supplementary files
